Alvotech Targets MENA In Multi-Biosimilar Commercialization Deal

The Three Partners Are Based Across Europe And North Africa

 
• By Rosalind Rei

Three firms across Europe and North Africa sign to sell Alvotech biosimilar candidates in 19 MENA countries as the Icelandic developer shifts focus from R&D to global commercialization.

Satellite image of MENA region at night showing light from urban areas
Alvotech continues to cultivate commercial partnerships in the MENA region • Source: Shutterstock

More from Biosimilars

More from Products